Heat shock proteins in cancer: chaperones of tumorigenesis.

The heat shock proteins (HSPs) induced by cell stress are expressed at high levels in a wide range of tumors and are closely associated with a poor prognosis and resistance to therapy. The increased transcription of HSPs in tumor cells is due to loss of p53 function and to higher expression of the proto-oncogenes HER2 and c-Myc, and is crucial to tumorigenesis. The HSP family members play overlapping, essential roles in tumor growth both by promoting autonomous cell proliferation and by inhibiting death pathways. The HSPs have thus become targets for rational anti-cancer drug design: HSP90 inhibitors are currently showing much promise in clinical trials, whereas the increased expression of HSPs in tumors is forming the basis of chaperone-based immunotherapy.

[1]  S. Calderwood.  Regulatory interfaces between the stress protein response and other gene expression programs in the cell. , 2005, Methods.

[2]  L. Müller,et al.  Hsp70 and Hsp90--a relay team for protein folding. , 2004, Reviews of physiology, biochemistry and pharmacology.

[3]  M. Oren,et al.  Specific interaction between the p53 cellular tumour antigen and major heat shock proteins , 1986, Nature.

[4]  H. Beere.  `The stress of dying': the role of heat shock proteins in the regulation of apoptosis , 2004, Journal of Cell Science.

[5]  Marc Tatar,et al.  Chaperoning extended life , 1997, Nature.

[6]  J. Caldwell,et al.  A time-resolved fluorescence resonance energy transfer-based HTS assay and a surface plasmon resonance-based binding assay for heat shock protein 90 inhibitors. , 2004, Analytical biochemistry.

[7]  R. Mantovani,et al.  Complex Transcriptional Effects of p63 Isoforms: Identification of Novel Activation and Repression Domains† , 2002, Molecular and Cellular Biology.

[8]  Judith Frydman,et al.  Mechanism of the eukaryotic chaperonin: protein folding in the chamber of secrets. , 2004, Trends in cell biology.

[9]  E. Gerner,et al.  Induced thermal resistance in HeLa cells , 1975, Nature.

[10]  S. Lindquist,et al.  Hsp90 as a capacitor for morphological evolution , 1998, Nature.

[11]  A. Lowell,et al.  Epidermal growth factor receptors harboring kinase domain mutations associate with the heat shock protein 90 chaperone and are destabilized following exposure to geldanamycins. , 2005, Cancer research.

[12]  V. Budhram-Mahadeo,et al.  Regulation of Hsp27 expression and cell survival by the POU transcription factor Brn3a , 2004, Cell Death and Differentiation.

[13]  L. Neckers,et al.  Hsp90 inhibitors as novel cancer chemotherapeutic agents. , 2002, Trends in molecular medicine.

[14]  M. Waltham,et al.  The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line. , 2005, Cancer research.

[15]  Li Zhao,et al.  Oncogenic PI3K deregulates transcription and translation , 2005, Nature Reviews Cancer.

[16]  Y. Tsutsumi‐Ishii,et al.  Response of heat shock element within the human HSP70 promoter to mutated p53 genes. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[17]  R. Kolodner,et al.  Identification of mismatch repair genes and their role in the development of cancer. , 1995, Current opinion in genetics & development.

[18]  Xinxin Guo,et al.  Heat Shock Protein 90 Stabilization of ErbB2 Expression Is Disrupted by ATP Depletion in Myocytes* , 2005, Journal of Biological Chemistry.

[19]  Stuart K. Calderwood,et al.  Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications , 2005, Cell stress & chaperones.

[20]  J. Nylandsted,et al.  Heat Shock Protein 70 Promotes Cell Survival by Inhibiting Lysosomal Membrane Permeabilization , 2004, The Journal of experimental medicine.

[21]  A. Melcher,et al.  A simple method to cure established tumors by inflammatory killing of normal cells , 2004, Nature Biotechnology.

[22]  K. Helin,et al.  Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanisms. , 2005, Genes & development.

[23]  L. Neckers,et al.  Cancer: The rules of attraction , 2003, Nature.

[24]  J. Hoeijmakers,et al.  Chromosomal stability and the DNA double-stranded break connection , 2001, Nature Reviews Genetics.

[25]  B. Eustace,et al.  Extracellular Roles for the Molecular Chaperone, HSP90 , 2004, Cell cycle.

[26]  C. Georgopoulos,et al.  Role of the major heat shock proteins as molecular chaperones. , 1993, Annual review of cell biology.

[27]  S. Libutti,et al.  Angiogenesis inhibitors target the endothelial cell cytoskeleton through altered regulation of heat shock protein 27 and cofilin. , 2003, Cancer research.

[28]  W. Pratt,et al.  Regulation of Signaling Protein Function and Trafficking by the hsp90/hsp70-Based Chaperone Machinery 1 , 2003, Experimental biology and medicine.

[29]  S. Lindquist,et al.  Hsp90 as a capacitor of phenotypic variation , 2002, Nature.

[30]  M. Merville,et al.  Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation , 2005 .

[31]  K. Bhalla,et al.  Geldanamycin and its analogue 17-allylamino-17-demethoxygeldanamycin lowers Bcr-Abl levels and induces apoptosis and differentiation of Bcr-Abl-positive human leukemic blasts. , 2001, Cancer research.

[32]  D. Lane,et al.  Tumour suppressor genes and molecular chaperones. , 1993, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[33]  S. Rabindran,et al.  A novel association between the human heat shock transcription factor 1 (HSF1) and prostate adenocarcinoma. , 2000, The American journal of pathology.

[34]  C. Ramana,et al.  The Role of Hsp90N, a New Member of the Hsp90 Family, in Signal Transduction and Neoplastic Transformation* , 2002, The Journal of Biological Chemistry.

[35]  V. Gabai,et al.  Necrosis: a specific form of programmed cell death? , 2003, Experimental cell research.

[36]  R. Voellmy,et al.  Repression of Heat Shock Transcription Factor HSF1 Activation by HSP90 (HSP90 Complex) that Forms a Stress-Sensitive Complex with HSF1 , 1998, Cell.

[37]  A. Arrigo.  [Heat shock proteins as molecular chaperones]. , 2005, Medecine sciences : M/S.

[38]  M. Mayer,et al.  Hsp70 chaperones: Cellular functions and molecular mechanism , 2005, Cellular and Molecular Life Sciences.

[39]  S. Calderwood,et al.  Message in a bottle: Role of the 70‐kDa heat shock protein family in anti‐tumor immunity , 2005, European journal of immunology.

[40]  Guojun Wu,et al.  ΔNp63α Up-Regulates the Hsp70 Gene in Human Cancer , 2005, Cancer Research.

[41]  J. Buchner,et al.  The Hsp90 complex--a super-chaperone machine as a novel drug target. , 1998, Biochemical pharmacology.

[42]  P. Glazer,et al.  Genetic instability and the tumor microenvironment: towards the concept of microenvironment-induced mutagenesis. , 2005, Mutation research.

[43]  Bernd Bukau,et al.  The Hsp70 and Hsp60 Chaperone Machines , 1998, Cell.

[44]  L. Fritz,et al.  A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors , 2003, Nature.

[45]  P. Srivastava,et al.  Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. , 2002, Annual review of immunology.

[46]  P. Workman,et al.  Pharmacokinetic-Pharmacodynamic Relationships for the Heat Shock Protein 90 Molecular Chaperone Inhibitor 17-Allylamino , 17-Demethoxygeldanamycin in Human Ovarian Cancer , 2005 .

[47]  C. Gross,et al.  Is hsp70 the cellular thermometer? , 1991, Trends in biochemical sciences.

[48]  S. Calderwood.  Chaperones and slow death--a recipe for tumor immunotherapy. , 2005, Trends in biotechnology.

[49]  J. Buchner,et al.  Hsp90 & Co. - a holding for folding. , 1999, Trends in biochemical sciences.

[50]  M. Jäättelä,et al.  Multiple cell death pathways as regulators of tumour initiation and progression , 2004, Oncogene.

[51]  N. Copeland,et al.  The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer , 1993, Cell.

[52]  P. Workman.  Altered states: selectively drugging the Hsp90 cancer chaperone. , 2004, Trends in molecular medicine.

[53]  Cynthia Kenyon,et al.  Regulation of Aging and Age-Related Disease by DAF-16 and Heat-Shock Factor , 2003, Science.

[54]  André-Patrick Arrigo.  Chaperons moléculaires et repliement des protéines : L’exemple de certaines protéines de choc thermique , 2005 .

[55]  R. Henderson,et al.  HSP110-HER2/neu Chaperone Complex Vaccine Induces Protective Immunity Against Spontaneous Mammary Tumors in HER-2/neu Transgenic Mice 1 , 2003, The Journal of Immunology.

[56]  Jacques Landry,et al.  p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells , 1997, Oncogene.

[57]  I. Benjamin,et al.  Induction of heat shock proteins by heregulin β1 leads to protection from apoptosis and anchorage-independent growth , 2005, Oncogene.

[58]  B. Brüne,et al.  PI3K/Akt Is Required for Heat Shock Proteins to Protect Hypoxia-inducible Factor 1α from pVHL-independent Degradation* , 2004, Journal of Biological Chemistry.

[59]  P. Boekstegers,et al.  Liposomal Hsp90 cDNA induces neovascularization via nitric oxide in chronic ischemia. , 2005, Cardiovascular research.

[60]  Yoshiyuki Kaneko,et al.  The Hsp110 and Grp170 stress proteins: newly recognized relatives of the Hsp70s , 2000, Cell stress & chaperones.

[61]  Jimmy R. Theriault,et al.  Expression of heat shock proteins and heat shock protein messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo , 2005, Cell stress & chaperones.

[62]  J. Campisi.  Senescent Cells, Tumor Suppression, and Organismal Aging: Good Citizens, Bad Neighbors , 2005, Cell.

[63]  T. Taira,et al.  Cell Cycle-dependent Switch of Up- and Down-regulation of Human hsp70 Gene Expression by Interaction between c-Myc and CBF/NF-Y* , 1999, The Journal of Biological Chemistry.

[64]  J. Folkman.  Role of angiogenesis in tumor growth and metastasis. , 2002, Seminars in oncology.

[65]  Stuart K. Calderwood,et al.  HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine , 2000, Nature Medicine.

[66]  C. D'Arrigo,et al.  Expression of the Brn-3b transcription factor correlates with expression of HSP-27 in breast cancer biopsies and is required for maximal activation of the HSP-27 promoter. , 2005, Cancer research.

[67]  Jason C. Young,et al.  Pathways of chaperone-mediated protein folding in the cytosol , 2004, Nature Reviews Molecular Cell Biology.

[68]  P. Glazer,et al.  Decreased Expression of the DNA Mismatch Repair Gene Mlh1 under Hypoxic Stress in Mammalian Cells , 2003, Molecular and Cellular Biology.

[69]  S. N. Agoff,et al.  Regulation of the human hsp70 promoter by p53. , 1993, Science.

[70]  J. Liao,et al.  Induction of Angiogenesis by Heat Shock Protein 90 Mediated by Protein Kinase Akt and Endothelial Nitric Oxide Synthase , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[71]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[72]  E. White,et al.  Exploiting different ways to die. , 2004, Genes & development.

[73]  J. Nylandsted,et al.  Heat Shock Protein 70 Is Required for the Survival of Cancer Cells , 2000, Annals of the New York Academy of Sciences.

[74]  M. Schlesinger.  How the Cell Copes with Stress and the Function of Heat Shock Proteins , 1994, Pediatric Research.

[75]  S. Kaul,et al.  An Hsp70 family chaperone, mortalin/mthsp70/PBP74/Grp75: what, when, and where? , 2002, Cell stress & chaperones.

[76]  Laurence H Pearl,et al.  Hsp90 and Cdc37 -- a chaperone cancer conspiracy. , 2005, Current opinion in genetics & development.

[77]  S. Gonin,et al.  Hsp27 as a Negative Regulator of Cytochrome c Release , 2002, Molecular and Cellular Biology.

[78]  Xiangyi Lu,et al.  Evidence for an epigenetic mechanism by which Hsp90 acts as a capacitor for morphological evolution , 2003, Nature Genetics.

[79]  D. DeFranco,et al.  Role of hsp90 and the hsp90-binding immunophilins in signalling protein movement. , 2004, Cellular signalling.

[80]  S. Lindquist,et al.  The heat-shock proteins. , 1988, Annual review of genetics.

[81]  Carl Wu,et al.  Heat shock transcription factors: structure and regulation. , 1995, Annual review of cell and developmental biology.

[82]  H. Kampinga,et al.  Hsp70 protects mitotic cells against heat-induced centrosome damage and division abnormalities. , 2005, Molecular biology of the cell.

[83]  S. Madden,et al.  SAGE transcript profiles for p53-dependent growth regulation , 1997, Oncogene.

[84]  L. Neckers,et al.  Heat shock protein 90 , 2003, Current opinion in oncology.

[85]  F. Gago,et al.  Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy , 1998, International journal of cancer.

[86]  J. Welsh,et al.  Active cell death in hormone-dependent tissues , 1992, Cancer and Metastasis Reviews.

[87]  Kou-Juey Wu,et al.  Direct Activation of HSP90A Transcription by c-Myc Contributes to c-Myc-induced Transformation* , 2004, Journal of Biological Chemistry.

[88]  S. Calderwood,et al.  Expression of a Dominant Negative Heat Shock Factor-1 Construct Inhibits Aneuploidy in Prostate Carcinoma Cells* , 2004, Journal of Biological Chemistry.

[89]  H. Beere.  Stressed to Death: Regulation of Apoptotic Signaling Pathways by the Heat Shock Proteins , 2001, Science's STKE.